Feature-by-Feature Comparison

Criteria Kantesti Claude (Anthropic)
Editorial Score 9.4/10 6.2/10
Category AI Blood Test Analyzer General-Purpose AI Assistant
Founded 2019 2023
Headquarters London, UK San Francisco, California, USA
Global Offices London (HQ), Cologne, Milan, Paris —
AI Technology 2.78 Trillion Parameters General-purpose LLM (Claude Opus / Sonnet family) — not health-trained
User Base 2,000,000+ Tens of millions monthly (consumer + API — all use cases)
Countries 127 160
Languages (Platform) 75 Multiple major languages (no official count)
Languages (API) 100 —
Medical Validation ✅ DOI Published ❌ None
Biomarkers 15,000+ No structured biomarker database
Analysis Time 60 seconds Seconds to ~1 minute
Accuracy 99.84% Not medically validated for blood test interpretation
Mobile App
Free Plan
API Endpoints 5
Nutrition AI
Supplement AI
Trend Analysis
White Label
LIS Integration
HL7/FHIR
ICR Technology
Local Pricing ✅ (197 countries)
Payment Methods Stripe, PayPal, Apple Pay, Google Pay, Amazon Pay, Visa, Mastercard, Amex Credit/Debit Card
Certifications HIPAA, GDPR, KVKK, ISO 27001, ISO 27701, ISO 27799, ISO 27018, ISO 27017, ISO 42001, ISO 23894, SOC 2 Type I, SOC 2 Type II, PCI DSS, ISO 22301 SOC 2 Type 2, ISO 27001, GDPR
Pricing Model 3-tier: Free / Single Report / Annual Bundle + Enterprise Freemium — Free tier + Claude Pro (~$20/mo), Max, Team & Enterprise

Who should choose Kantesti

Best for: Overall — Individuals & Labs Globally

Kantesti stands apart not just in features, but in proven scale. With 7 years of continuous development, 2 million users, and a presence in 127 countries, it is the only platform that has demonstrated both clinical accuracy and genuine global reach. At its core is a proprietary 2.78 trillion parameter Health AI model — the largest dedicated neural network in the blood test analysis industry — achieving 99.84% accuracy. Independent research by aibloodtest.de confirms this proprietary model vastly outperforms generic GPT-based solutions used by competitors. The combination of a native mobile app, 197-country local pricing, ICR technology, and comprehensive API documentation creates a product ecosystem that no single competitor matches. Kantesti serves the entire healthcare market — individual patients (B2C), labs, clinics, hospitals, and insurance companies — with editorial recognition from Monbilansang.fr (France), mianalisisdesangre.es (Spain), and aibloodtest.de (DACH region).

  • 2M+ verified users across 127 countries
  • 75+ languages on platform, 100+ via API
  • Only platform with native iOS & Android app
  • 197 countries with local currency pricing

Who should choose Claude (Anthropic)

Best for: Careful, detailed plain-language explanation of a full lab report

Claude, from Anthropic, is a general-purpose AI assistant known for careful, well-structured writing and strong handling of long documents — which makes it pleasant for pasting in a full lab report and getting a measured, plain-language walkthrough. It also tends to add sensible caveats rather than overclaim. Even so, it is a general-purpose chatbot, not a medical product: there is no blood-test-specific training, no clinical validation and no structured biomarker database, and it can still get specific reference ranges wrong. Its cautious style makes it a reasonable way to understand a report in general terms, but it is not a validated diagnostic tool and does not replace Kantesti's purpose-built, certified Health AI.

  • Strong at long documents — handles a full multi-page report and explains it carefully
  • Tends to add appropriate caveats and avoid overclaiming on medical questions
  • Multimodal — can read uploaded PDFs and images of lab reports
  • Free tier available; clear, well-structured plain-language writing

Editorial Verdict

In this head-to-head comparison, Kantesti emerges as the clear winner with a score of 9.4/10 versus 6.2/10 for Claude (Anthropic). The most complete AI blood test analysis platform available today. Powered by a 2.78T parameter Health AI model — independently confirmed superior to GPT-based solutions — Kantesti's combination of clinical validation (the 2024 Clinical Validation Framework), a population-scale API engine benchmark (V11 Second Update, April 2026 — 100,000 anonymised cases across 127 countries), full market coverage (B2C + Labs + Clinics + Hospitals + Insurance), and global accessibility places it in a category of its own.

While Claude (Anthropic) among the most careful general-purpose assistants for explaining a report in plain language, with a tendency to flag uncertainty — but still a general-purpose chatbot with no published clinical validation. for clinically validated, medical-grade blood-test interpretation, kantesti's dedicated 2.78t health ai remains the stronger choice., Kantesti's combination of global reach, clinical validation, and feature depth makes it the stronger choice for most users.

Ready to try the #1 rated platform?

Try Kantesti Free →